Compare PMVP & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PMVP | PETS |
|---|---|---|
| Founded | 2013 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Retail-Drug Stores and Proprietary Stores |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.0M | 63.7M |
| IPO Year | 2020 | N/A |
| Metric | PMVP | PETS |
|---|---|---|
| Price | $1.25 | $3.16 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 1 | 1 |
| Target Price | ★ $5.00 | $3.20 |
| AVG Volume (30 Days) | 263.3K | ★ 7.7M |
| Earning Date | 11-12-2025 | 02-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $198,265,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.98 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.81 | $1.57 |
| 52 Week High | $1.84 | $5.58 |
| Indicator | PMVP | PETS |
|---|---|---|
| Relative Strength Index (RSI) | 49.35 | 58.79 |
| Support Level | $1.21 | $3.36 |
| Resistance Level | $1.27 | $3.64 |
| Average True Range (ATR) | 0.06 | 0.41 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 77.78 | 47.87 |
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.